After COVID-19, what’s next for EU medicines policies?

After COVID-19, what’s next for EU medicines policies?

After COVID-19, what’s next for EU medicines policies?  9 March 2021  16:00 - 17:00 CET  Online Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry...